Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Incyte keeps the ASCO spotlight focused on its closely-watched IDO1 drug epacadostat
Incyte keeps the ASCO spotlight focused on its closely-watched IDO1 drug epacadostat
Incyte keeps the ASCO spotlight focused on its closely-watched IDO1 drug epacadostat
Submitted by
admin
on June 5, 2017 - 10:08am
Source:
Endpoints
News Tags:
Incyte
ASCO 2017
epacadostat
non-small cell lung cancer
Keytruda
Headline:
Incyte keeps the ASCO spotlight focused on its closely-watched IDO1 drug epacadostat
Do Not Allow Advertisers to Use My Personal information
